BioSpace News Archive

Drug Development

Amgen’s Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis

October 27, 2008
·
15 min read
Drug Development

Biocryst Pharmaceuticals Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza Management to Host Conference Call at 8:30 a.m. Eastern Time Today to Discuss Results

October 27, 2008
·
8 min read
Drug Development

Exiqon A/S Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer

October 27, 2008
·
4 min read
Drug Development

Rib-X Pharmaceuticals, Inc. Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting

October 27, 2008
·
6 min read
Drug Development

Panacos Pharmaceuticals Inc. Presents Phase 2b Bevirimat Data at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

October 27, 2008
·
1 min read
Drug Development

Potentia Pharmaceuticals, Inc. to Present ASaP Phase I Clinical Trial Data for POT-4 at the American Academy of Ophthalmology Annual Meeting

October 27, 2008
·
3 min read
Lone Star Bio

T-System Releases The T SystemEV(R) 2.6.3, Featuring New Meds/Allergies Notification, Automated Charge Capture

October 27, 2008
·
4 min read
Antisense Therapeutics Limited to Present at Rodman & Renshaw 10th Annual Healthcare Conference

October 27, 2008
·
1 min read
Biotech Beach

North American Scientific Inc. Regains Compliance on Nasdaq Capital Market

October 27, 2008
·
1 min read
Job Trends

Misonix Incorporated Expands Contract Sales Organization for Distribution of SonicOne(TM) Wound Management System in the United States

October 27, 2008
·
1 min read